Evidence map›Paper›PMID 26839398›Full record

ReviewDisease models & mechanisms2016

Echoes of the embryo: using the developmental biology toolkit to study cancer.

Nicole M Aiello, Ben Z Stanger

Open access · goldAbstract readReview
In one paragraph

Review in Disease models & mechanisms, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 127 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Tumors and their microenvironments: Learning from pediatric brain pathologies.Biochimica et biophysica acta. Reviews on cancer · 2025
    Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. A fetal oncogene NUAK2 is an emerging therapeutic target in glioblastoma.bioRxiv : the preprint server for biology · 2025
    Article
  16. Article
  17. Cancer as a Disease of Development Gone Awry.Annual review of pathology · 2024
    Review
  18. Article
  19. Review
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Nicole M AielloDepartments of Medicine and Cell and Developmental Biology, Abramson Family Cancer Research Institute, and Institute for Regenerative Medicine, Perelman School of Medicine at the University of Pennsylvania, 421 Curie Boulevard, Philadelphia, PA 19104, USA.
Ben Z StangerDepartments of Medicine and Cell and Developmental Biology, Abramson Family Cancer Research Institute, and Institute for Regenerative Medicine, Perelman School of Medicine at the University of Pennsylvania, 421 Curie Boulevard, Philadelphia, PA 19104, USA bstanger@exchange.upenn.edu.
University of Pennsylvania · US

Funding

Immunobiology and immunotherapy of pancreatic cancerR01CA169123 · NCI · UNIVERSITY OF PENNSYLVANIA · PI STANGER, BEN Z, VONDERHEIDE, ROBERT H · 2012 to 2016
$3.1M
Elucidating the role and regulation of epithelial plasticity in metastasisF31CA177163 · NCI · UNIVERSITY OF PENNSYLVANIA · PI AIELLO, NICOLE · 2014 to 2016
$87k
NCI NIH HHS F31 CA177163NCI NIH HHS F31-CA177163-01A1NCI NIH HHS R01 CA169123NCI NIH HHS R01-CA169123
6 · The paper itself

Abstract

The hallmark of embryonic development is regulation - the tendency for cells to find their way into organized and 'well behaved' structures - whereas cancer is characterized by dysregulation and disorder. At face value, cancer biology and developmental biology would thus seem to have little to do with each other. But if one looks beneath the surface, embryos and cancers share a number of cellular and molecular features. Embryos arise from a single cell and undergo rapid growth involving cell migration and cell-cell interactions: features that are also seen in the context of cancer. Consequently, many of the experimental tools that have been used to study embryogenesis for over a century are well-suited to studying cancer. This article will review the similarities between embryogenesis and cancer progression and discuss how some of the concepts and techniques used to understand embryos are now being adapted to provide insight into tumorigenesis, from the origins of cancer cells to metastasis.

Indexed as

Embryonic DevelopmentAntineoplastic AgentsBiomarkers, TumorCarcinogenesisEpithelial-Mesenchymal TransitionHumansMutationNeoplasmsAntineoplastic AgentsBiomarkers, TumorCancerEmbryologyIntravital imagingLineage tracingReprogramming

Identifiers

PMID26839398
PMCPMC4770149
OpenAlexW2259318229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.